Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Other events
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement
  16. 4/A Insider Changes in Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 8-K Event Executive or director change

Page 27 of 30 · 587 filings